<--- Back to Details
First PageDocument Content
Diols / Fingolimod / Natalizumab / Alemtuzumab / Immune system / Immunosuppressants / Immunology / Multiple sclerosis
Date: 2015-03-16 01:05:14
Diols
Fingolimod
Natalizumab
Alemtuzumab
Immune system
Immunosuppressants
Immunology
Multiple sclerosis

Public Summary Document – November 2014 PBAC MeetingALEMTUZUMAB solution for infusion, 10 mg/ mL; Lemtrada®; Genzyme (Sanofi-Aventis Australia Pty Ltd). 1

Add to Reading List

Source URL: www.pbs.gov.au

Download Document from Source Website

File Size: 414,36 KB

Share Document on Facebook

Similar Documents